Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01276236 · ClinicalTrials.gov registry record · Phase 2
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)
A Phase 2 study of Kaposi's Sarcoma, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT01276236 is a Phase 2 study of Kaposi's Sarcoma that has completed, run by University of California, San Francisco. The registered enrollment target is 13 participants, below the 452-participant average among 3 other Kaposi's Sarcoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01276236, a Phase 2 study of Kaposi's Sarcoma, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pilot study is to determine whether Maraviroc is effective in the treatment of Kaposi's Sarcoma (KS), when it does not remit with standard antiretroviral drug therapy.
Conditions Studied
Interventions
- DRUG Maraviroc
Study Locations (1)
California
- San Francisco General Hospital, Clinical Trials Unit - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2011-03-09 |
| Est. Completion | 2015-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01276236
The ClinicalTrials.gov registry entry for NCT01276236 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 452-participant average among 3 other Kaposi's Sarcoma trials with a reported enrollment target (97% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Kaposi's Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Maraviroc is the first listed.
NCT01276236 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01276236 about?
NCT01276236 is a clinical study titled "Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS)". The purpose of this pilot study is to determine whether Maraviroc is effective in the treatment of Kaposi's Sarcoma (KS), when it does not remit with standard antiretroviral drug therapy.
What is the current status of trial NCT01276236?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2011-03-09. Estimated completion is 2015-04-30.
What conditions does trial NCT01276236 study?
This clinical trial studies the following conditions: Kaposi's Sarcoma.
What interventions are being tested in trial NCT01276236?
The interventions under investigation include: Maraviroc (DRUG).
Who is sponsoring clinical trial NCT01276236?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01276236 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kaposi's Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
RECRUITING
-
Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease
RECRUITING
-
Twins Study of Gene Therapy for HIV Infection
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.